Conservancy of the α 4β 7 integrin mimotope in the V2 domain of HIV type 1 CRF07-BC compared to subtype b' strains in China

AIDS Research and Human Retroviruses

Volumn 27, Issue 10, 2011, Pages 1127-1133

  He, Xiang ^a   Mokili, John L ^b,c   Hong, Kunxue ^a   Chen, Jianping ^a   Wei, Jing ^a   Xin, Ruolei ^a   Song, Yan Hui ^a   Feng, Yi ^a   Jia, Mingming ^a   Xing, Hui ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c Global Viral Forecasting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; INTEGRIN; UNCLASSIFIED DRUG;

BINDING SITE; CD4+ T LYMPHOCYTE; CHINA; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNINDEXED SEQUENCE; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; CHINA; EVOLUTION, MOLECULAR; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INTEGRINS; PHYLOGENY; PROTEIN CONFORMATION; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT;

EID: 80053639841     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0007     Document Type: Review

References (28)

1. Frenette PS and Wagner DD: Adhesion molecules-Part 1. N Engl J Med 1996;334:1526-1529.
2. 7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382:366-370. (Pubitemid 26260466)
3. 7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008;9:301-309. (Pubitemid 351267327)
4. 7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci USA 2009;106:20877-20882.
5. Derdeyn CA, Decker JM, Bibollet-Ruche F, et al.: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004;303:2019-2022. (Pubitemid 38393277)
6. 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol 2007;81:5658-5668. (Pubitemid 46847005)
7. Haase AT: Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005;5:783-792. (Pubitemid 41400852)
8. Mehandru S, Poles MA, Tenner-Racz K, et al.: Mechanisms of gastrointestinal CD4 + T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 2007;81:599-612. (Pubitemid 46067887)
9. Xu JQ, Wang JJ, Han LF, et al.: Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China. Chin Med J (Engl) 2006;119:1941-1948.
10. Liu S, Xing H, He X, et al.: Analysis of putative N-linked glycosylation sites and variable region of envelope HIV-1 CRF07-BC recombinant in intravenous drug users in Xinjiang Autonomous Region, China. AIDS Res Hum Retro-viruses 2008;24:521-527.
11. Zhou XL, He X, Hong KX, et al.: [Genetic variation of gag gene in HIV-1 subtype B infections from Henan and Shanxi provinces of China]. Bing Du Xue Bao 2009;25: 95-100.
12. Ruan Y, Qin G, Liu S, et al.: HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. J Acquir Immune Defic Syndr 2005;39:459-463. (Pubitemid 41003793)
13. Shao Y, Zhao F and Yang W: [The identification of recom-binant HIV-1 strains in IDUs in southwest and northwest China]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999;13:109-112.
14. Li Y, Cleveland B, Klots I, et al.: Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J Virol 2008;82:638-651.
15. Shannon CE: A mathematical theory of communication. Bell System Technical J 1948;27:379-423 and 623-656.
16. O'Rourke SM, Schweighardt B, Phung P, et al.: Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. J Virol 2010;84:11200-11209.
17. Gaschen B, Kuiken C, Korber B, and Foley B: Retrieval and on-the-fly alignment of sequence fragments from the HIV database. Bioinformatics 2001;17:415-418. (Pubitemid 32440301)
18. Cao J, Sullivan N, Desjardin E, et al.: Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glyco-protein. J Virol 1997;71:9808-9812. (Pubitemid 27492434)
19. Cheng-Mayer C, Brown A, Harouse J, Luciw PA, and Mayer AJ: Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 1999; 73:5294-5300. (Pubitemid 29274810)
20. Johnson WE, Sanford H, Schwall L, et al.: Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J Virol 2003; 77:9993-10003. (Pubitemid 37122081)
21. Ye Y, Si ZH, Moore JP, and Sodroski J: Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo. J Virol 2000;74:11955-11962. (Pubitemid 32222346)
22. Ashkenazi A, Smith DH, Marsters SA, et al.: Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci USA 1991;88:7056-7060. (Pubitemid 21915088)
23. Koch M, Pancera M, Kwong PD, et al.: Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 2003;313:387-400. (Pubitemid 37045357)
24. Kwong PD, Wyatt R, Majeed S, et al.: Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 2000;8:1329-1339. (Pubitemid 32149759)
25. Seaman MS, Janes H, Hawkins N, et al.: Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol 2010;84:1439-1452.
26. Moore PL, Ranchobe N, Lambson BE, et al.: Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog 2009;5: e1000598.
27. Rong R, Li B, Lynch RM, et al.: Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 2009;5: e1000594.
28. Wei X, Decker JM, Wang S, et al.: Antibody neutralization and escape by HIV-1. Nature 2003;422:307-312 (Pubitemid 36378357)